Look for:

Our offer for

Research Detail

2023/03/28 / Erste Group Research

Pharma Stocks with Good Prospects


Rating Changes: Adobe, NextEra Energy, Regeneron Pharma, Nutrien, Walmart

Earnings estimates for the US equity market are positive for 2023. Although earnings are still expected to decline in 1Q and 2Q: 1Q 23e: -6% (y/y), 2 Q23e: -3% (y/y), there is an increase in earnings for the full year, according to the consensus forecast. Accordingly, the median expected 2023 profit growth is +9% (y/y).

The reporting season for 4Q results is over. The new reporting season does not start until April14 with US bank results. Equity investors will now increasingly turn their attention back to economic risks.

Regeneron Pharma: Successful phase III study in COPD drug

Beiersdorf: 2022 Organic sales growth of +10.2% y/y, Consumer margin improvement of 50BP in 2023e
BMW: Sales growth of +28% y/y, EBIT margin target 2023 reaffirmed

PDF Download Download PDF (5.6MB)

General information

AuthorErste Group Research
Date2023/03/28
Languageen
Product nameRecommendation List
Topic in focusEquities
Economy in focusEurozone, Germany, Switzerland, United Kingdom, United States
Currency in focusBritish Pound, Euro, Swiss Franc, US Dollar
Sector in focusAutomobiles & Parts, Banks, Basic Resources, Chemicals, Construction & Material, Financial Services, Food & Beverage, Health Care, Industrial Goods & Services, Insurance, Media, Oil & Gas, Personal & Household Goods, Retail, Technology, Telecommunications, Travel & Leisure, Utilities
Download

Related financial instruments

Page 5 of 6
Name  ISIN# Erste Group products
SanofiFR00001205780
SAPDE00071646004
Schneider Electric FR00001219720
ServiceNowUS81762P10210
ShellGB00B03MLX290
SiemensDE00072361010
Southern CoUS84258710710
StarbucksUS85524410940
T-Mobile USUS87259010400
Taiwan SemiconductorTW00023300080
TencentKYG8757216340
Tesla US88160R10140
Thermo Fisher ScientificUS88355610230
Tokyo ElectronJP35714000050
TotalEnergiesFR00001202710
Toyota MotorJP36334000010
UBSCH02447675850
UniCreditIT00052393600
UnileverGB00B10RZP780
UnitedHealth GroupUS91324P10210
ValeBRVALEACNOR00
VerizonUS92343V10440
Vertex Pharmaceuticals US92532F10030
Vestas Wind SystemsDK00102686060
Vinci FR00001254860



Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer